statement by Tibayan and associates 4 gives supporting evidence for our hypothesis. Other suggestions may also provide alternative explanations for superiority of complete rings relative to partial ones. As Kwon and colleagues 1 mentioned, although complete rings are better for the treatment of functional mitral regurgitation, they need further advances in multiple aspects to be considered as the best treatment option, because recurrence rates are still high. We think that the complete rings are quite well in fixing septolateral dimension changes at the annular level; however, they are not adequate for fixing septolateral dimension changes at the equatorial level of the left ventricle. That is why increased preoperative left ventricular dimension with a left ventricular enddiastolic diameter greater than 65 mm is the most accepted preoperative risk factor for higher rate of recurrence after ring annuloplasty in functional mitral regurgitation, as Kwon and colleagues 1 mentioned in their article.
We believe that brainstorming regarding the underlying mechanism of recurrence will improve our knowledge and understanding of functional mitral regurgitation.
INSERTION OF PAPILLARY MUSCLE INSTEAD OF LEFT VENTRICULAR REDUCTION To the Editor:
We congratulate Michler and colleagues 1 on their successful surgery and excellent study recently reported online in the Journal. We would also like to highlight some issues.
In the article's Figure E4 , A, 1 there was no reduction in left ventricular end-systolic volume index (LVESVI) in patients undergoing coronary bypass grafting (CABG), and left ventricular ejection fraction did not increase either (as seen in the article's Table 2 1 ) . Nevertheless, left ventricular ejection fraction did increase significantly in patients with CABG plus surgical ventricular reconstruction (SVR), and we therefore propose that volume reduction is also necessary for the initial CABG-only group.
In the article's Figure E4 , B, 1 LVESVI could be seen to drop as low as 30 mL/m 2 (normal volume) in many patients undergoing CABG plus SVR. So although ischemia was relieved by CABG, some dilatation may remain as a result of the continuation of relative ischemia, according to Laplace's law. SVR should therefore be expanded to include the mitral annulus and ventricular base. In addition, the existence of cases with a LVESVI drop to 20 mL/m 2 in the article's Figure E4 , A, 1 leads us to think that an off-pump procedure should be preferred.
Instead of left ventricular reduction, 2 the insertion of papillary muscle to the ventricular wall could be palpated from outside on the beating heart, and the apex could be plicated by inserting pledgeted sutures anteroposteriorly and mediolaterally at this level. The ventricular cavity thus could be reduced near the base externally ( Figure 1 recently published online in the Journal. Building on their previous study, 2 they have conducted 2 impressive independent works to explore the cardioprotection by remote ischemic preconditioning (RIPC) with isoflurane 3 or propofol 1 in coronary artery bypass grafting (CABG). [1] [2] [3] There has always been concern regarding whether b-blockers could interfere with the cardioprotective effect of RIPC. In their fundamental study, 2 the mean b-blocker usage rates were 60% in the propofol substudy and 64% in the isoflurane substudy, and a better preservation of RIPCinduced cardioprotection with isoflurane than propofol was proposed. This difference seems to remain unchanged in the population, however, with higher proportion of b-blocker medication (83% in propofol 1 group and 87% in isoflurane). 3 Their series of studies indicates that the anesthetic choice is more critical than b-blocker use in the interference of cardioprotection by RIPC.
Nevertheless, our group's recent meta-analysis, 4 which included 15 randomized, controlled trials with 
